Article
Untangling the loops of STAG2 mutations in myelodysplastic syndrome.
Leukemia & lymphoma - 1 Jan 2025
Sudunagunta Varun S, Viny Aaron D
Abstract excerpt
Myelodysplastic syndrome (MDS) is a heterogeneous myeloid neoplasm that is hallmarked by the acquisition of genetic events that disrupt normal trilineage hematopoiesis and results in bone marrow dysfunction. Somatic genes involving transcriptional regulation, signal transduction, DNA methylation, and chromatin modification are often implicated in disease pathogenesis. The cohesin complex, composed of SMC1, SMC3,...
Topics
- Humans
- Myelodysplastic Syndromes
- Mutation
- Cell Cycle Proteins
- Cohesins
- Antigens, Nuclear
- Chromosomal Proteins, Non-Histone
- Prognosis
- Genetic Predisposition to Disease
